STOCK TITAN

Amrize Ltd Financials

AMRZ
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Amrize Ltd (AMRZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 49 / 100
Financial Profile 49/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
58

Amrize Ltd has an operating margin of 16.1%, meaning the company retains $16 of operating profit per $100 of revenue. This results in a moderate score of 58/100, indicating healthy but not exceptional operating efficiency. This is down from 18.8% the prior year.

Growth
35

Amrize Ltd's revenue grew a modest 0.9% year-over-year to $11.8B. This slow but positive growth earns a score of 35/100.

Leverage
85

Amrize Ltd carries a low D/E ratio of 0.83, meaning only $0.83 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
28

Amrize Ltd's current ratio of 1.64 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 28/100, which could limit financial flexibility.

Cash Flow
55

Amrize Ltd has a free cash flow margin of 12.0%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
31

Amrize Ltd's ROE of 8.9% shows moderate profitability relative to equity, earning a score of 31/100. This is down from 12.8% the prior year.

Altman Z-Score Grey Zone
2.61

Amrize Ltd scores 2.61, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($31.5B) relative to total liabilities ($11.0B). This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Weak
3/9

Amrize Ltd passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.86x

For every $1 of reported earnings, Amrize Ltd generates $1.86 in operating cash flow ($2.2B OCF vs $1.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
8.8x

Amrize Ltd earns $8.8 in operating income for every $1 of interest expense ($1.9B vs $216.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$11.8B
YoY+0.9%

Amrize Ltd generated $11.8B in revenue in fiscal year 2025. This represents an increase of 0.9% from the prior year.

EBITDA
$2.7B
YoY-9.1%

Amrize Ltd's EBITDA was $2.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 9.1% from the prior year.

Net Income
$1.2B
YoY-7.0%

Amrize Ltd reported $1.2B in net income in fiscal year 2025. This represents a decrease of 7.0% from the prior year.

EPS (Diluted)
$2.14
YoY-7.0%

Amrize Ltd earned $2.14 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 7.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$1.4B
YoY-13.4%

Amrize Ltd generated $1.4B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 13.4% from the prior year.

Cash & Debt
$1.9B
YoY+21.3%

Amrize Ltd held $1.9B in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
553M

Amrize Ltd had 553M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin
25.7%
YoY-0.6pp

Amrize Ltd's gross margin was 25.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the prior year.

Operating Margin
16.1%
YoY-2.6pp

Amrize Ltd's operating margin was 16.1% in fiscal year 2025, reflecting core business profitability. This is down 2.6 percentage points from the prior year.

Net Margin
10.0%
YoY-0.9pp

Amrize Ltd's net profit margin was 10.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.9 percentage points from the prior year.

Return on Equity
8.9%
YoY-3.9pp

Amrize Ltd's ROE was 8.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$788.0M
YoY+22.7%

Amrize Ltd invested $788.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 22.7% from the prior year.

AMRZ Income Statement

Metric Q4'25 Q3'25 Q2'25 Q4'24 Q3'24 Q2'24
Revenue N/A $3.7B+14.1% $3.2B N/A $3.4B+6.3% $3.2B
Cost of Revenue N/A $2.6B+14.9% $2.3B N/A $2.4B+6.2% $2.3B
Gross Profit N/A $1.1B+12.4% $966.0M N/A $1.0B+6.4% $979.0M
R&D Expenses N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A $312.0M+4.3% $299.0M N/A $241.0M+5.7% $228.0M
Operating Income N/A $778.0M+16.3% $669.0M N/A $844.0M+11.9% $754.0M
Interest Expense N/A $79.0M+46.3% $54.0M N/A $11.0M+10.0% $10.0M
Income Tax N/A $150.0M+23.0% $122.0M N/A $155.0M+4.0% $149.0M
Net Income N/A $545.0M+27.0% $429.0M N/A $553.0M+16.7% $474.0M
EPS (Diluted) N/A $0.98+25.6% $0.78 N/A $1.00+16.3% $0.86

AMRZ Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q4'24 Q3'24 Q2'24
Total Assets $24.2B+0.9% $24.0B+1.1% $23.8B-0.1% $23.8B N/A N/A
Current Assets $4.7B+2.5% $4.6B+5.6% $4.3B-9.5% $4.8B N/A N/A
Cash & Equivalents $1.9B+132.7% $826.0M+37.4% $601.0M-62.1% $1.6B+277.4% $420.0M+16.7% $360.0M
Inventory $1.6B+2.6% $1.5B-7.9% $1.6B+13.0% $1.5B N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A
Goodwill $9.0B+0.3% $9.0B-0.4% $9.0B+1.3% $8.9B N/A N/A
Total Liabilities $11.0B-1.3% $11.1B-1.9% $11.3B-18.3% $13.9B N/A N/A
Current Liabilities $2.9B-9.4% $3.2B+0.3% $3.1B+23.3% $2.5B N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A
Total Equity $13.3B+2.8% $12.9B+3.8% $12.4B+25.4% $9.9B+0.8% $9.8B+5.7% $9.3B
Retained Earnings $902.0M+50.1% $601.0M+918.6% $59.0M $0 N/A N/A

AMRZ Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $1.8B+111.2% $854.0M N/A $1.7B+177.2% $623.0M N/A
Capital Expenditures $157.0M-15.1% $185.0M N/A $84.0M-62.0% $221.0M N/A
Free Cash Flow $1.6B+146.2% $669.0M N/A $1.6B+308.7% $402.0M N/A
Investing Cash Flow -$150.0M+25.7% -$202.0M N/A -$352.0M+17.2% -$425.0M N/A
Financing Cash Flow -$577.0M-37.7% -$419.0M N/A -$163.0M-14.0% -$143.0M N/A
Dividends Paid N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A

AMRZ Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A 29.5%-0.5pp 30.0% N/A 30.2%+0.1pp 30.2%
Operating Margin N/A 21.2%+0.4pp 20.8% N/A 24.5%+1.2pp 23.3%
Net Margin N/A 14.8%+1.5pp 13.3% N/A 16.1%+1.4pp 14.6%
Return on Equity N/A 4.2%+0.8pp 3.5% N/A 5.6%+0.5pp 5.1%
Return on Assets N/A 2.3%+0.5pp 1.8% N/A N/A N/A
Current Ratio 1.64+0.2 1.45+0.1 1.38-0.5 1.87 N/A N/A
Debt-to-Equity 0.83-0.0 0.86-0.0 0.91-0.5 1.40 N/A N/A
FCF Margin N/A 18.2% N/A N/A 11.7% N/A

Similar Companies

Frequently Asked Questions

Amrize Ltd (AMRZ) reported $11.8B in total revenue for fiscal year 2025. This represents a 0.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Amrize Ltd (AMRZ) revenue grew by 0.9% year-over-year, from $11.7B to $11.8B in fiscal year 2025.

Yes, Amrize Ltd (AMRZ) reported a net income of $1.2B in fiscal year 2025, with a net profit margin of 10.0%.

Amrize Ltd (AMRZ) reported diluted earnings per share of $2.14 for fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amrize Ltd (AMRZ) had EBITDA of $2.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Amrize Ltd (AMRZ) had a gross margin of 25.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Amrize Ltd (AMRZ) had an operating margin of 16.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Amrize Ltd (AMRZ) had a net profit margin of 10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Amrize Ltd (AMRZ) has a return on equity of 8.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Amrize Ltd (AMRZ) generated $1.4B in free cash flow during fiscal year 2025. This represents a -13.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Amrize Ltd (AMRZ) generated $2.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Amrize Ltd (AMRZ) had $24.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Amrize Ltd (AMRZ) invested $788.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Amrize Ltd (AMRZ) had 553M shares outstanding as of fiscal year 2025.

Amrize Ltd (AMRZ) had a current ratio of 1.64 as of fiscal year 2025, which is generally considered healthy.

Amrize Ltd (AMRZ) had a debt-to-equity ratio of 0.83 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Amrize Ltd (AMRZ) had a return on assets of 4.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Amrize Ltd (AMRZ) has an Altman Z-Score of 2.61, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Amrize Ltd (AMRZ) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Amrize Ltd (AMRZ) has an earnings quality ratio of 1.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Amrize Ltd (AMRZ) has an interest coverage ratio of 8.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Amrize Ltd (AMRZ) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top